期刊文献+

2012年肾脏疾病主要临床进展 被引量:9

下载PDF
导出
摘要 盘点2012年肾脏病诊疗领域与其他学科一样精彩纷呈,2012改善全球肾脏疾病预后组织(KDIGO)推出多项指南;在减少蛋白尿、延缓慢性。肾脏病(CKD)进展、肾替代治疗等方面都有很多的证据,当然也有争论,现综述如下,供同道参考。
作者 傅淑霞
出处 《临床荟萃》 CAS 2013年第4期361-367,共7页 Clinical Focus
  • 相关文献

参考文献46

  • 1Eknoyan G, Eckardt KU, Kasiske BL, et al. KDIGO Clinical Practice Guideline for Glomerulonephritis [J] Kidney Int, 2012,2(Suppl 2) : 143 -153.
  • 2Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury[J]. Nephron Clin Pract, 2012,120(4) : 179-184.
  • 3Eknoyan G, Lameire N, Eckardt KU, et al. KDIGO Clinical Practice Guidelinefor Anemia in Chronic Kidney Disease[J]. Kidney International,2012,2(Suppl 2):279-335.
  • 4Zeng CH, Le W, Ni Z, et al. A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients[J]. Am J Kidney Dis, 2012,60 (5) : 812- 820.
  • 5Maeda I, Hayashi T, Sato KK, et al. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy[J]. Nephrol Dial Transplant, 2012,27 (7) :2806-2813.
  • 6Tatematsu M, Yasuda Y, Morita Y, et al. Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy[J]. Clin Exp Nephrol'2012,16(6) : 883 8891.
  • 7Zhang Q, Shi SF, Zhu L, et al. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy[J]. Am J Nephrol,2012,35(4) :312-320.
  • 8Cheng J, Zhang X, Tian J, et al. Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis[J]. Int J Clin Pract, 2012, 66 (10) :917-923.
  • 9Tang SC, Lin M, Tam S, et al. Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study[J]. Nephrol Dial Transplant,2012,27(2) :613-618.
  • 10Ros-Ruiz S,Aranda-Lara P,Fern/mdez JC, et al. High doses of irbesartan offer long-term kidney protection in cases of established diabetic nephropathy[J]. Nefrologia, 2012,32 (2) : 187-196.

同被引文献49

  • 1陈楠,陈佳韵.重视微量白蛋白尿的筛查与诊治[J].实用医院临床杂志,2005,2(1):17-19. 被引量:26
  • 2王妍.日本肾脏学会发表慢性肾脏病诊疗指南[J].日本医学介绍,2007,28(9):429-429. 被引量:4
  • 3苏定冯.心血管药理学[M].4版.北京:人民卫生出版社,2011:501-537.
  • 4Bell M,Liljestam E, Granath F, et al. Optimal follow-up tim(after continuous renal replacement therapy in actual renafailure patients stratified with the RIFLE criteria[J]. Nephro-Dial Transplant,2005,20(2) :354-360.
  • 5Mommsen P,Frink M,Pape HC’et al. Elevated systemic IL-1and neopterin levels are associated with posttraumati(complications among patients with multiple injuries: iprospective cohort study[J]. Injury ,2009 ,40(5) : 528-534.
  • 6Molitoris BA, Levin A, Warnock DG, et al. Improvingoutcomes of acute kidney injury: report of an initiative[JG. NatClin Pract Nephrol,2007,3(8) :439-442.
  • 7Taber SS,Pasko DA. The epidemiology of drug-induceddisorders: the kidney [J]. Expert Opin Drug Saf, 2008, 7(6):679-690'.
  • 8Matsui K, Kamijo-Ikemori A, Sugaya T, et al. Usefulness ofurinary biomarkers in early detection of acute kidney injuryafter cardiac surgery in adults [J]. Circ J,2012,76(1):213-220.
  • 9He Z,Lu L, Altmann C,Hoke TS,et al. Interleukin-18 bindingprotein transgenic mice are protected against ischemic acutekidney injury [J]. Am J Physiol Renal Physiol. 2008,295(5):1414-1421.
  • 10Pedra JH, Cassel SL,Sutterwala FS. Sensing pathogens anddanger signals by the inflammasome[J]. Curr Opin Immunol,2009,21 (1):10-16.

引证文献9

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部